Roche’s response to the COVID-19 pandemic

Our commitment to help put a stop to the COVID-19 pandemic


Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic. Around the world, we are working with urgency, passion and purpose each and every day to deliver high quality tests that are essential for healthcare systems and patients alike.


Timely availability and fast access to reliable, high quality tests are essential for healthcare systems.


Thomas Schinecker
Chief Executive Officer of Roche Diagnostics

Real-time RT-PCR test


Detecting SARS-CoV-2 in currently infected patients with high sensitivity


The cobas® SARS-CoV-2 Test is a real-time RT-PCR test intended for the qualitative detection of SARS-CoV-2 in nasopharyngeal and oropharyngeal swab samples from patients.

This test can run on Roche’s fully automated cobas® 6800 and cobas® 8800 Systems under Emergency Use Authorization. The test is also available for countries accepting the CE-mark.

Antibody test


Detecting a patient’s immune response to SARS CoV-2 with high specificity


The Elecsys® Anti-SARS-CoV-2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma. The test is intended as an aid in the determination of the immune reaction to SARS-CoV-2.

The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers..

When to use which
SARS‑CoV‑2 diagnostic test1


Reliable diagnostic tests targeting patients that are currently infected by the virus, as well as those that have an immune response against the virus, are valuable. However, it is important to understancd which tests are most suitable to use depending on their intended purpose.

icon of a person

Is my sickness COVID‑19?

Tests that detect the virus


  • RT-PCR 
  • Antigen tests
icon of a person

How is my body's immune system reacting to the virus?

Tests that detect immune response and potential immunity*


  • Antibody tests

*Whether immunity is gained by individuals who have been infected with SARS-CoV-2 is yet to be confirmed due to the novelty of the virus. Data presented here are based on current scientific understanding of the disease (April 2020)

An overview of SARS-CoV-2 diagnostic tests available


Watch this video which explains the different diagnostic tests available for SARS-CoV-2 and when they are most effectively used.


Literature update on valuable biomarkers in COVID-19

In the face of this SARS-CoV-2 pandemic, we are witnessing an increasing number of publications referring to the possible use of existing biomarkers in patients with COVID-19. Applications for biomarkers are wide-ranging and can have a pivotal impact on clinical practice. However, sifting through high volumes of information is time-consuming and no easy task. 

In order to simplify this for you, we have selected relevant - and recently published - scientific articles that explore the role of various biomarkers in COVID-19. As the COVID-19 outbreak is recent and not all published articles have been peer-reviewed, we've made sure to indicate which of these references have not benefited from this peer-review.

You can consult an overview of key messages with the help of a short summary per biomarker, as well as a summary of each article once you click on the link below.


Go to Literature Updates



COVID-19: coronavirus disease 2019

RT-PCR: reverse transcription polymerase chain reaction

  1. European Commision (2020). Guidelines on COVID-19 in vitro diagnostic tests and their performance (published 15 April 2020). Available from [Accessed April 2020]